Abstract:Background Neoantimycins are a group of 15-membered ring depsipeptides isolated from Streptomycetes with a broad-spectrum of anticancer activities. Neoantimycin biosynthesis is directed by the hybrid multimodular megaenzymes of non-ribosomal peptide synthetase and polyketide synthase. We previously discovered a new neoantimycin analogue unantimycin B, which was demonstrated to have selective anticancer activities and was produced from the neoantimycin biosynthetic pathway with a starter unit of 3-hydroxybenzoate, instead of the 3-formamidosalicylate unit that is common for neoantimycins. However, the low fermentation titre and tough isolation procedure have hindered in-depth pharmacological investigation of unantimycin B as an anticancer agent. Results In this work, we genetically constructed two unantimycin B producer strains and inhibited neoantimycins production by removing nat O and nat J-L genes essential for 3-formamidosalicylate biosynthesis, therefore facilitating chromatographic separation of unantimycin B from the complex fermentation extract. Based on the Δ nat O mutant, we improved unantimycin B production twofold, reaching approximately 12.8 mg/L, by feeding 3-hydroxybenzoate during fermentation. Furthermore, the production was improved more than sixfold, reaching approximately 40.0 mg/L, in the Δ nat O strain introduced with a chorismatase gene highly expressed under a strong promoter for endogenously over-producing 3-hydroxybenzoate. Conclusion This work provides a case of targeting accumulation and significant production improvement of medicinally interesting natural products via genetic manipulation of precursor biosynthesis in Streptomycetes , the talented producers of pharmaceutical molecules.

Heterologous Production of the C33-C45 Polyketide Fragment of Anticancer Apratoxins in a Cyanobacterial Host

Heterologous Production of Epothilone C and D in Escherichia coli

Synthesis, Conformational Analysis and Biological Evaluation of the Lactam Analogue of the Cyclodepsipeptide Apratoxin A

High-Titer Heterologous Production in E. coli of Lyngbyatoxin, a Protein Kinase C Activator from an Uncultured Marine Cyanobacterium

Bioconversion of Deoxysugar Moieties to the Biosynthetic Intermediates of Daunorubicin in an Engineered Strain of Streptomyces Coeruleobidus

Dynemicin A Derivatives as Potential Cancer Chemotherapeutics by Mutasynthesis

Reassembly of the Biosynthetic Gene Cluster Enables High Epothilone Yield in Engineered Schlegelella Brevitalea.

[The PKS/NRPS Hetero-Gene Cluster of Epothilones].

Chaetoxylariones A–G: Undescribed Chromone-Derived Polyketides from Co-Culture of Chaetomium Virescens and Xylaria Grammica Enabled Via the Molecular Networking Strategy

Production of a Trioxacarcin Analogue by Engineering of Its Biosynthetic Pathway

Heterologous Production and Yield Improvement of Epothilones in Burkholderiales Strain DSM 7029

Discovery, Structure Correction, and Biosynthesis of Actinopyrones, Cytotoxic Polyketides from the Deep-Sea Hydrothermal-Vent-Derived <i>Streptomyces</i> sp. SCSIO ZS0520

Heterologous expression of an engineered biosynthetic pathway: functional dissection of type II polyketide synthase components in Streptomyces species

Refactoring the Concise Biosynthetic Pathway of Cyanogramide Unveils Spirooxindole Formation Catalyzed by A P450 Enzyme

Divergent Synthesis of Revised Apratoxin E, 30-epi-Apratoxin E, and 30S/30R-Oxoapratoxin E

Chalkophomycin Biosynthesis Revealing Unique Enzyme Architecture for a Hybrid Nonribosomal Peptide Synthetase and Polyketide Synthase

Heterologous Production of the Marine Myxobacterial Antibiotic Haliangicin and Its Unnatural Analogues Generated by Engineering of the Biochemical Pathway

Engineering of an industrial polyoxin producer for the rational production of hybrid peptidyl nucleoside antibiotics.

The Catalytically Lignan-Activation-Based Approach for the Synthesis of (Epi)-Podophyllotoxin Derivatives.

Heterologous expression of the diazaquinomycin biosynthetic gene cluster

Targeted Accumulation of Selective Anticancer Depsipeptides by Reconstructing the Precursor Supply in the Neoantimycin Biosynthetic Pathway